Medicine Price Transparency Under Scrutiny At Next World Health Assembly
At the forthcoming 72nd World Health Assembly, delegates will discuss a resolution calling for greater transparency on medicine prices.
You may also be interested in...
A draft resolution on the transparency of medicine prices and R&D costs is being discussed this week by World Health Organization members, but the pharmaceutical industry says some measures will be damaging for medicines access.
New medicines under evaluation at the European Medicines Agency.
The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.